MPA

Drug / Medication

Medroxyprogesterone acetate, a synthetic form of progesterone used in the Women's Health Initiative study. The speaker suggests this synthetic component may have contributed to negative findings, particularly regarding breast cancer risk.

Mentioned in 1 video